IGeneX
PrivateLast Round
Buyout/LBO
Sep 17, 2015
Company Overview
IGeneX is a biotechnology company that provides specialized laboratory diagnostic testing services for Lyme disease and other tick-borne illnesses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IGeneX Comparables
Compare IGeneX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galaxy Diagnostics, Inc. | 89% | |
| T Lab Inc. | 79% | |
| ArminLabs | 77% | |
IGeneX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Sep 17, 2015 |
IGeneX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Balance Point Capital | Buyout/LBO |
| 4C Capital | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 31% MoM to 28.4K.
- Sep 17, 2015
Led by 4C Capital and Balance Point Capital.
IGeneX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IGeneX's valuation, stock price, and market status.